Skip to main content

CORRECTION article

Front. Immunol., 24 July 2018
Sec. Cancer Immunity and Immunotherapy
Volume 9 - 2018 | https://doi.org/10.3389/fimmu.2018.01719

Corrigendum: Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model

This article is a correction to:

  1. Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model

    1. Read original article
\r\nSharon Wei Ling Lee,,&#x;Sharon Wei Ling Lee1,2,3†Giulia Adriani&#x;Giulia Adriani1†Erica Ceccarello,&#x;Erica Ceccarello2,4†Andrea PavesiAndrea Pavesi4Anthony Tanoto TanAnthony Tanoto Tan5Antonio BertolettiAntonio Bertoletti5Roger Dale Kamm,*Roger Dale Kamm1,6*Siew Cheng Wong,*\r\nSiew Cheng Wong2,3*
  • 1BioSystems and Micromechanics IRG, Singapore-MIT Alliance for Research and Technology, Singapore, Singapore
  • 2Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
  • 3Singapore Immunology Network (SIgN), Biomedical Sciences Institute, Agency for Science, Technology, and Research, Singapore, Singapore
  • 4Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research, Singapore, Singapore
  • 5Programme of Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore
  • 6Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States

A corrigendum on

Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model
by Lee SWL, Adriani G, Ceccarello E, Pavesi A, Tan AT, Bertoletti A, et al. Front Immunol (2018) 9:416. doi: 10.3389/fimmu.2018.00416

In our original research article, there was an error in the Materials and Methods section, subsection 3D Microfluidic Co-Culture and Blocking Experiments, where it was written that 100 µg/mL of anti-PD-L1-blocking or anti-PD-1-blocking antibody or their respective isotype control was used. The correct concentration is 10 µg/mL. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

The original article has been updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: microfluidics, monocytes, T cell receptor-redirected T cells, immunotherapy, immune checkpoint, PD-L1, tumor microenvironment

Citation: Lee SWL, Adriani G, Ceccarello E, Pavesi A, Tan AT, Bertoletti A, Kamm RD and Wong SC (2018) Corrigendum: Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model. Front. Immunol. 9:1719. doi: 10.3389/fimmu.2018.01719

Received: 12 June 2018; Accepted: 12 July 2018;
Published: 24 July 2018

Edited and Reviewed by: Vincenzo Bronte, Università degli Studi di Verona, Italy

Copyright: © 2018 Lee, Adriani, Ceccarello, Pavesi, Tan, Bertoletti, Kamm and Wong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Roger Dale Kamm, rdkamm@mit.edu;
Siew Cheng Wong, wong_siew_cheng@immunol.a-star.edu.sg

†These authors have contributed equally to this work.

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.